Arcadi Cipponi
Impact in
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 5%
- Chemokine receptors and signaling
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 10
- Immunotherapy and Immune Responses 8
- T-cell and B-cell Immunology 6
- Immune Cell Function and Interaction 5
- Oncology 9
- Chemokine receptors and signaling 3
- CAR-T cell therapy research 3
- Cancer-related Molecular Pathways 2
- Co-authors
- Claudio Bordignon (6 shared papers)Alessandro Aiuti (4 shared papers)Pierre G. Coulie (3 shared papers)Nicolas van Baren (2 shared papers)Marguerite Stas (1 shared paper)Thierry Boon (1 shared paper)Ivan Théate (1 shared paper)Elisabetta Zappone (1 shared paper)
- Journals
- Blood (2 papers)Nature Communications (1 paper)Journal of Clinical Oncology (1 paper)Journal of Biological Chemistry (1 paper)Journal of Clinical Investigation (1 paper)
- Partner nations
- ItalyUnited StatesAustralia
In The Last Decade
Arcadi Cipponi
13 papers receiving 783 citations
Peers
Comparison fields: 5 of 64
- Immunology 445
- Oncology 444
- Hematology 120
- Virology 42
- Immunology and Allergy 46
Countries citing papers authored by Arcadi Cipponi
This map shows the geographic impact of Arcadi Cipponi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arcadi Cipponi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arcadi Cipponi more than expected).
Fields of papers citing papers by Arcadi Cipponi
This network shows the impact of papers produced by Arcadi Cipponi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arcadi Cipponi. The network helps show where Arcadi Cipponi may publish in the future.
Co-authors
The 25 scholars most cited alongside Arcadi Cipponi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 208 | |
| 2 | 1999 | 164 | |
| 3 | Human CD34(+) cells express CXCR4 and its ligand stromal cell-derived factor-1. Implications for infection by T-cell tropic human immunodeficiency virus. | 1999 | 100 |
| 4 | 1999 | 94 | |
| 5 | 2011 | 49 | |
| 6 | 2013 | 46 | |
| 7 | 2005 | 38 | |
| 8 | 2008 | 36 | |
| 9 | 2007 | 22 | |
| 10 | 2019 | 16 | |
| 11 | 2014 | 8 | |
| 12 | 2024 | 5 | |
| 13 | 1999 | 3 | |
| 14 | 2006 | 1 |
About Arcadi Cipponi
Arcadi Cipponi is a scholar working on Immunology, Oncology, Genetics, Molecular Biology and Virology, having authored 14 papers that have together received 790 indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (8 papers), T-cell and B-cell Immunology (6 papers), Immune Cell Function and Interaction (5 papers), Chemokine receptors and signaling (3 papers), CAR-T cell therapy research (3 papers), Cancer-related Molecular Pathways (2 papers), HIV Research and Treatment (2 papers) and Sarcoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Immunology (445 citations), Oncology (444 citations), Hematology (120 citations), Virology (42 citations) and Immunology and Allergy (46 citations). Arcadi Cipponi has collaborated with scholars based in Italy, United States and Australia. Frequent co-authors include Claudio Bordignon, Alessandro Aiuti, Pierre G. Coulie, Nicolas van Baren, Marguerite Stas, Thierry Boon, Ivan Théate, Elisabetta Zappone, Joost van den Oord and Bruno Péault. Their work appears in journals such as Blood, Nature Communications, Journal of Clinical Oncology, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.